BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25374634)

  • 1. [Massive pleural effusion after surgery of breast cancer and early discontinuation of tamoxifen: about an observation].
    Ngombe LK; Kangulu IB; Nday CM; Tshanda MN; Ngoy Lumbule J; Matanga PM; Sampatwa ON; Nzaji MK
    Pan Afr Med J; 2014; 17():129. PubMed ID: 25374634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen-induced sexual dysfunction in a breast cancer patient: a case report.
    Barni S; Ardizzoia A
    Tumori; 1998; 84(3):417-8. PubMed ID: 9678629
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fatal hypercalcemia in tamoxifen. Chief symptom: increasing somnolence in a 68-year-old patient].
    Mayer O; Hricko P; Bernhard P; Leibundgut U
    Praxis (Bern 1994); 1999 Nov; 88(46):1923-4. PubMed ID: 10593148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
    Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype.
    Alramadhan M; Ryu JM; Rayzah M; Nam SJ; Kim SW; Yu J; Lee SK; Bae SY; Park S; Paik HJ; Lee JE
    Breast; 2016 Dec; 30():111-117. PubMed ID: 27697675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinvasive lobular carcinoma of the breast.
    Howat AJ; Armour A; Ellis IO
    Histopathology; 2000 Nov; 37(5):477-8. PubMed ID: 11119139
    [No Abstract]   [Full Text] [Related]  

  • 8. A case for Tamoxifen with ovarian function suppression.
    Kopparthy P; Daily K
    Breast Cancer Res Treat; 2020 Aug; 183(1):241-242. PubMed ID: 32601972
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen increases von Willebrand factor in women who underwent breast cancer surgery.
    Blann AD; Baildam AD; Howell A; Miller JP
    Thromb Haemost; 2001 May; 85(5):941-2. PubMed ID: 11372695
    [No Abstract]   [Full Text] [Related]  

  • 10. New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer.
    Rosenberg SM; Partridge AH
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26307642
    [No Abstract]   [Full Text] [Related]  

  • 11. Lobular carcinoma of the male breast.
    Michaels BM; Nunn CR; Roses DF
    Surgery; 1994 Mar; 115(3):402-5. PubMed ID: 8128366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of adjuvant endocrine therapy for postoperative breast cancer patients].
    Doihara H; Ogasawara Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():563-7. PubMed ID: 17682212
    [No Abstract]   [Full Text] [Related]  

  • 13. The Atlas trial: Tamoxifen for a longer duration for early breast cancer.
    Raina V
    Natl Med J India; 2013; 26(1):4-5. PubMed ID: 24066985
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature.
    Bock VL; Friedlander M; Waring D; Kossard S; Wood GK
    Australas J Dermatol; 2014 Nov; 55(4):282-5. PubMed ID: 24575835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast cancer metastasis in distal phalanx of the big toe. Case report].
    Carlesimo B; Tempesta M; Fioramonti P; Bistoni G; Ruggiero M; Marchetti F
    G Chir; 2009; 30(11-12):487-9. PubMed ID: 20109377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in hepatic parenchymal ultrasound images in tamoxifen medication patients.
    Nagaie T; Hashimoto M; Kai M; Yamashiata N; Kondo J; Tokunaga M; Miyazaki M; Wakiyama S; Watanabe M; Toyomasu T; Shirabe K
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1925-8. PubMed ID: 16282728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
    Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
    Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid metastasis of lobular breast carcinoma].
    Egaña N; Socias C; Matteucci T; Bilbao I; Alvarez-Coca M
    Endocrinol Nutr; 2012 Mar; 59(3):219-20. PubMed ID: 22138624
    [No Abstract]   [Full Text] [Related]  

  • 19. Metastatic breast cancer 39 years after primary treatment.
    Mamby CC; Love RR; Heaney E
    Wis Med J; 1993 Oct; 92(10):567-9. PubMed ID: 8266714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate ATAC on tamoxifen.
    Coates A; Mouridsen H; Thürlimann B;
    Lancet Oncol; 2008 Apr; 9(4):315-6. PubMed ID: 18374287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.